세계의 마이크로니들 인플루엔자 백신 시장 보고서(2025년)

Microneedle Flu Vaccine Global Market Report 2025

US $ 4,490 ￦ 6,217,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,987,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,756,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

마이크로니들 인플루엔자 백신 시장 규모는 향후 몇 년 동안 빠르게 성장하여 2029년까지 10.4%의 CAGR로 24억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장의 원동력은 전염병 대응 이니셔티브의 확대, 비침습적 백신 접종 방식에 대한 선호도 증가, 독감 이외의 질병에 대한 마이크로니들의 광범위한 적용, 환자 친화적인 백신 접종 옵션에 대한 수요 증가, 마이크로니들 패치의 제조 확장성 강화입니다. 이 기간의 주요 동향으로는 용해성 마이크로니들 기술로의 전환, 자가 투여 백신 모델에 대한 관심 증가, 마이크로니들과 웨어러블 건강 모니터링 시스템과의 통합, 마이크로니들 기반 인플루엔자 백신의 임상시험 증가, 소아 및 노인 인구에 대한 마이크로니들 플랫폼의 채택 등이 있습니다. 마이크로니들 플랫폼의 채택 등이 있습니다.

바늘 공포증의 유병률 증가는 마이크로 니들 인플루엔자 백신 시장의 성장을 촉진할 것으로 예상됩니다. 바늘 공포증은 바늘 공포증으로도 알려져 있으며, 바늘을 사용하는 시술의 광경, 감각 및 예상에 의해 유발되는 강한 두려움이나 불안으로, 종종 필요한 의료 개입을 피하도록 개인을 이끌 수 있습니다. 이 증상은 주로 심리적 과민 반응과 과거의 부정적인 경험에 의해 유발되어 장기적인 두려움과 회피 행동을 유발합니다. 마이크로 니들 인플루엔자 백신은 최소침습적이고 통증이 거의 없는 대안을 제공하여 백신 접종에 대한 심리적 장벽을 줄이고 환자의 순응도를 향상시키고 있습니다. 예를 들어, 2025년 2월 미국임상병리학회(ASCP)는 약 50-60%의 어린이가 주사바늘 공포증을 경험하고 있으며, 4-6세 사이에 공포증이 가장 만연하다고 보고했습니다. 그 결과, 주사바늘 공포증의 유병률 증가는 마이크로니들 인플루엔자 백신 시장의 확대에 기여하고 있습니다.

마이크로니들 인플루엔자 백신 시장의 주요 기업들은 패치형 RNA 백신 개발을 가속화하기 위한 투자 확보에 주력하고 있습니다. 이러한 노력은 초기 단계의 연구와 공동 연구를 지원하여 차세대 백신 전달 기술을 발전시키고 있습니다. 예를 들어, 2024년 3월 미국 정부 기관인 Biomedical Advanced Research and Development Authority(BARDA)는 독감 및 COVID-19를 표적으로 하는 마이크로니들 패치 기반 RNA 백신의 개발을 신속히 진행하기 위해 신속한 개발을 위해 Patch Forward Prize를 통해 5,000만 달러를 투자할 것이라고 발표했습니다. 이 이니셔티브는 개념 개발 자금을 지원하고, 조합 제품의 임상 1상 시험으로의 전환을 지원함으로써 기술 혁신을 촉진하는 것을 목표로 하고 있습니다. 이 프로그램은 백신 개발자와 패치 제조업체 간의 협력을 촉진하여 기술 및 규제 문제를 극복하고, 백신 접근성을 개선하며, 감염성 질환에 대한 국가적 대비를 강화하기 위한 목적으로 시행됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 마이크로니들 인플루엔자 백신 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 마이크로니들 인플루엔자 백신 시장 : 성장률 분석
• 세계의 마이크로니들 인플루엔자 백신 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 마이크로니들 인플루엔자 백신 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 마이크로니들 인플루엔자 백신 전체 시장(TAM)

제6장 시장 세분화

• 세계의 마이크로니들 인플루엔자 백신 시장 : 제품 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 중공 마이크로니들
• 고체 마이크로니들
• 코팅 마이크로니들
• 용해 마이크로니들
• 세계의 마이크로니들 인플루엔자 백신 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 경구
• 비경구
• 비강
• 세계의 마이크로니들 인플루엔자 백신 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 마이크로니들 인플루엔자 백신 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 인플루엔자 예방 접종
• 계절성 인플루엔자 예방
• 소아 백신
• 노인용 백신
• 세계의 마이크로니들 인플루엔자 백신 시장, 중공 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 일회용 중공 마이크로니들
• 다용 도중 하늘 마이크로니들
• 폴리머 기반 중공 마이크로니들
• 실리콘 기반 중공 마이크로니들
• 세계의 마이크로니들 인플루엔자 백신 시장, 고체 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 금속 고체 마이크로니들
• 실리콘 고체 마이크로니들
• 폴리머 고체 마이크로니들
• 유리 고체 마이크로니들
• 세계의 마이크로니들 인플루엔자 백신 시장, 코팅 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 약제 코팅 마이크로니들
• 백신 코팅 마이크로니들
• 생분해성 코팅 마이크로니들
• 나노코팅 마이크로니들
• 세계의 마이크로니들 인플루엔자 백신 시장, 용해 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 속용성 마이크로니들
• 서방형 마이크로니들
• 하이드로겔 기반 용해 마이크로니들
• 당 기반 용해 마이크로니들

제7장 지역별·국가별 분석

• 세계의 마이크로니들 인플루엔자 백신 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 마이크로니들 인플루엔자 백신 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 마이크로니들 인플루엔자 백신 시장 : 경쟁 구도
• 마이크로니들 인플루엔자 백신 시장 : 기업 개요
  • Merck & Co. Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Novartis AG
  • Becton Dickinson and Company(BD)

제31장 기타 주요 기업과 혁신적 기업

• AptarGroup
• Corium International
• CosMED Pharmaceutical Co. Ltd.
• Vaxxas
• PharmaJet
• Inovio Pharmaceuticals
• Vaxess Technologies
• FluGen Inc.
• DebIoTech S.A.
• Micron Biomedical Inc.
• NanoPass Technologies Limited
• Micropoint Technologies Pte Ltd.
• TSRL Inc.
• Verndari Inc.
• Microdermics Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

• 마이크로니들 인플루엔자 백신 시장, 2029년 : 새로운 기회를 제공하는 국가
• 마이크로니들 인플루엔자 백신 시장, 2029년 : 새로운 기회를 제공하는 부문
• 마이크로니들 인플루엔자 백신 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

The microneedle flu vaccine is an innovative vaccination method that uses a small, patch-like array of microscopic needles to painlessly deliver the influenza vaccine into the skin. This approach offers a minimally invasive, efficient, and user-friendly alternative to traditional intramuscular injections. It is designed to enhance vaccine accessibility, increase patient compliance, facilitate self-administration, and improve immunization coverage, especially in large-scale public health initiatives.

The main product types of microneedle flu vaccines include hollow microneedles, solid microneedles, coated microneedles, and dissolving microneedles. A hollow microneedle is a micro-scale needle with a central lumen, allowing for the direct injection of liquid formulations into the skin. These vaccines can be administered through various routes, such as oral, parenteral, and nasal, and are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Applications for these vaccines include flu vaccination, seasonal flu prevention, pediatric vaccines, and vaccines for the elderly.

The microneedle flu vaccine market research report is one of a series of new reports from The Business Research Company that provides microneedle flu vaccine market statistics, including microneedle flu vaccine industry global market size, regional shares, competitors with a microneedle flu vaccine market share, detailed microneedle flu vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle flu vaccine industry. This microneedle flu vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle flu vaccine market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to the increasing global burden of seasonal influenza, rising awareness about the benefits of vaccination, government efforts to improve immunization coverage, a growing preference for minimally invasive drug delivery methods, and the early clinical success of microneedle vaccines in animal models.

The microneedle flu vaccine market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period is driven by the expansion of pandemic preparedness initiatives, increasing preference for needle-free vaccination methods, broader application of microneedles for diseases beyond influenza, rising demand for patient-friendly vaccination options, and enhanced manufacturing scalability of microneedle patches. Key trends during this period include a shift toward dissolvable microneedle technologies, a growing focus on self-administered vaccine models, integration of microneedles with wearable health monitoring systems, a rise in clinical trials for microneedle-based influenza vaccines, and the adoption of microneedle platforms for pediatric and elderly populations.

The increasing prevalence of needle phobia is expected to drive the growth of the microneedle flu vaccine market. Needle phobia, also known as trypanophobia, is an intense fear or anxiety triggered by the sight, sensation, or anticipation of needle-based procedures, often leading individuals to avoid necessary medical interventions. This condition is primarily fueled by psychological sensitivity and negative past experiences, creating long-term fear and avoidance behavior. Microneedle flu vaccines provide a minimally invasive and nearly painless alternative, which reduces psychological barriers to vaccination and encourages better patient compliance. For example, in February 2025, the American Society for Clinical Pathology (ASCP) reported that approximately 50% to 60% of children experience needle phobia, with the fear being most prevalent between the ages of 4 and 6. As a result, the growing prevalence of needle phobia is contributing to the expansion of the microneedle flu vaccine market.

Leading companies in the microneedle flu vaccine market are focusing on securing investments to accelerate the development of patch-based RNA vaccines. These efforts support early-stage research and collaboration, advancing next-generation vaccine delivery technologies. For example, in March 2024, the Biomedical Advanced Research and Development Authority (BARDA), a U.S.-based government agency, announced a $50 million investment through the Patch Forward Prize to fast-track the development of microneedle patch-based RNA vaccines targeting influenza and COVID-19. This initiative aims to drive innovation by funding concept development and supporting the progression of combination products into Phase I clinical trials. The program fosters collaboration between vaccine developers and patch manufacturers, with the goal of overcoming technical and regulatory challenges, improving vaccine accessibility, and bolstering national preparedness for infectious diseases.

In January 2024, Gylden Pharma Limited (formerly Emergex Vaccines Holding Limited), a UK-based clinical-stage biotechnology company, partnered with DEKA Research & Development Corp. to enhance patient-friendly drug delivery through advanced microneedle-based intradermal administration technologies. The collaboration seeks to evaluate the compatibility and effectiveness of combining Emergex's immunotherapeutic candidates with DEKA's microneedle applicator for potential clinical use. DEKA Research & Development Corp., a U.S.-based company specializing in microneedle solutions, will play a pivotal role in advancing this technology.

Major players in the microneedle flu vaccine market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Novartis AG, Becton Dickinson and Company (BD), AptarGroup, Corium International, CosMED Pharmaceutical Co. Ltd., Vaxxas, PharmaJet, Inovio Pharmaceuticals, Vaxess Technologies, FluGen Inc., Debiotech S.A., Micron Biomedical Inc., NanoPass Technologies Limited, Micropoint Technologies Pte Ltd., TSRL Inc., Verndari Inc., and Microdermics Inc.

North America was the largest region in the microneedle flu vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microneedle flu vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the microneedle flu vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microneedle flu vaccine market consists of sales of polymer-based microneedle patches, hydrogel-forming microneedles, silicon microneedle arrays, biodegradable microneedle systems, metallic microneedles, and lipid-based microneedle formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Flu Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microneedle flu vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle flu vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microneedle flu vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Hollow Microneedle; Solid Microneedle; Coated Microneedle; Dissolving Microneedle
• 2) By Route Of Administration: Oral; Parenteral; Nasal
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By Application: Flu Vaccination; Seasonal Flu Prevention; Pediatric Vaccines; Elderly Vaccines
• Subsegments:
• 1) By Hollow Microneedle: Single-Use Hollow Microneedles; Multiple-Use Hollow Microneedles; Polymer-Based Hollow Microneedles; Silicon-Based Hollow Microneedles
• 2) By Solid Microneedle: Metal Solid Microneedles; Silicon Solid Microneedles; Polymer Solid Microneedles; Glass Solid Microneedles
• 3) By Coated Microneedle: Drug-Coated Microneedles; Vaccine-Coated Microneedles; Biodegradable Coated Microneedles; Nano-Coated Microneedles
• 4) By Dissolving Microneedle: Fast-Dissolving Microneedles; Slow-Release Microneedles; Hydrogel-Based Dissolving Microneedles; Sugar-Based Dissolving Microneedles
• Companies Mentioned: Merck & Co. Inc.; Sanofi SA; AstraZeneca plc; Novartis AG; Becton Dickinson and Company (BD)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microneedle Flu Vaccine Market Characteristics

3. Microneedle Flu Vaccine Market Trends And Strategies

4. Microneedle Flu Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Microneedle Flu Vaccine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Microneedle Flu Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Microneedle Flu Vaccine Market Growth Rate Analysis
• 5.4. Global Microneedle Flu Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Microneedle Flu Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Microneedle Flu Vaccine Total Addressable Market (TAM)

6. Microneedle Flu Vaccine Market Segmentation

• 6.1. Global Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hollow Microneedle
• Solid Microneedle
• Coated Microneedle
• Dissolving Microneedle
• 6.2. Global Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Nasal
• 6.3. Global Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Microneedle Flu Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flu Vaccination
• Seasonal Flu Prevention
• Pediatric Vaccines
• Elderly Vaccines
• 6.5. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Hollow Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Hollow Microneedles
• Multiple-Use Hollow Microneedles
• Polymer-Based Hollow Microneedles
• Silicon-Based Hollow Microneedles
• 6.6. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Solid Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metal Solid Microneedles
• Silicon Solid Microneedles
• Polymer Solid Microneedles
• Glass Solid Microneedles
• 6.7. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Coated Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Coated Microneedles
• Vaccine-Coated Microneedles
• Biodegradable Coated Microneedles
• Nano-Coated Microneedles
• 6.8. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Dissolving Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fast-Dissolving Microneedles
• Slow-Release Microneedles
• Hydrogel-Based Dissolving Microneedles
• Sugar-Based Dissolving Microneedles

7. Microneedle Flu Vaccine Market Regional And Country Analysis

• 7.1. Global Microneedle Flu Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Microneedle Flu Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microneedle Flu Vaccine Market

• 8.1. Asia-Pacific Microneedle Flu Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microneedle Flu Vaccine Market

• 9.1. China Microneedle Flu Vaccine Market Overview
• 9.2. China Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microneedle Flu Vaccine Market

• 10.1. India Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microneedle Flu Vaccine Market

• 11.1. Japan Microneedle Flu Vaccine Market Overview
• 11.2. Japan Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microneedle Flu Vaccine Market

• 12.1. Australia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microneedle Flu Vaccine Market

• 13.1. Indonesia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microneedle Flu Vaccine Market

• 14.1. South Korea Microneedle Flu Vaccine Market Overview
• 14.2. South Korea Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microneedle Flu Vaccine Market

• 15.1. Western Europe Microneedle Flu Vaccine Market Overview
• 15.2. Western Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microneedle Flu Vaccine Market

• 16.1. UK Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microneedle Flu Vaccine Market

• 17.1. Germany Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microneedle Flu Vaccine Market

• 18.1. France Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microneedle Flu Vaccine Market

• 19.1. Italy Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microneedle Flu Vaccine Market

• 20.1. Spain Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microneedle Flu Vaccine Market

• 21.1. Eastern Europe Microneedle Flu Vaccine Market Overview
• 21.2. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microneedle Flu Vaccine Market

• 22.1. Russia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microneedle Flu Vaccine Market

• 23.1. North America Microneedle Flu Vaccine Market Overview
• 23.2. North America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microneedle Flu Vaccine Market

• 24.1. USA Microneedle Flu Vaccine Market Overview
• 24.2. USA Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microneedle Flu Vaccine Market

• 25.1. Canada Microneedle Flu Vaccine Market Overview
• 25.2. Canada Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microneedle Flu Vaccine Market

• 26.1. South America Microneedle Flu Vaccine Market Overview
• 26.2. South America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microneedle Flu Vaccine Market

• 27.1. Brazil Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microneedle Flu Vaccine Market

• 28.1. Middle East Microneedle Flu Vaccine Market Overview
• 28.2. Middle East Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microneedle Flu Vaccine Market

• 29.1. Africa Microneedle Flu Vaccine Market Overview
• 29.2. Africa Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microneedle Flu Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Microneedle Flu Vaccine Market Competitive Landscape
• 30.2. Microneedle Flu Vaccine Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Microneedle Flu Vaccine Market Other Major And Innovative Companies

• 31.1. AptarGroup
• 31.2. Corium International
• 31.3. CosMED Pharmaceutical Co. Ltd.
• 31.4. Vaxxas
• 31.5. PharmaJet
• 31.6. Inovio Pharmaceuticals
• 31.7. Vaxess Technologies
• 31.8. FluGen Inc.
• 31.9. Debiotech S.A.
• 31.10. Micron Biomedical Inc.
• 31.11. NanoPass Technologies Limited
• 31.12. Micropoint Technologies Pte Ltd.
• 31.13. TSRL Inc.
• 31.14. Verndari Inc.
• 31.15. Microdermics Inc.

32. Global Microneedle Flu Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microneedle Flu Vaccine Market

34. Recent Developments In The Microneedle Flu Vaccine Market

35. Microneedle Flu Vaccine Market High Potential Countries, Segments and Strategies

• 35.1 Microneedle Flu Vaccine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Microneedle Flu Vaccine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Microneedle Flu Vaccine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료